A dietary interview performed by expert personnel is the best method to check whether patients with coeliac disease follow a strict gluten-free diet (GFD). We previously developed a score based on flour fast and simple questions that can be administered even by non-expert personnel. The aim of the present study is to verify the reliability of our questionnaire in a new cohort of patients. The questionnaire has a five-level score. From March 2008 to January 2011, the questionnaire was administered to 141 coeliac patients on a GFD, who were undergoing re-evaluation. The score obtained was compared with persistence of both villous atrophy and endomysial antibodies (EMA). The rate of lower scores was higher among the patients with persistence of either villous atrophy (Fisher's excact, P < 0.001; test for trend, P < 0.001) or positive EMA (Fisher's exact, P = 0.001; test for trend, P = 0.018). Given that the coelic patients have been well instructed on what a GFD means and on how to follow it, our questionnaire is a reliable and simple method to verify compliance to a GFD.

A score that verifies adherence to a gluten-free diet: a corss-sectional, multicentre validation in real clinical life.

BIAGI, FEDERICO;MARCHESE, ALESSANDRA;TROTTA, LUCIA;CORAZZA, GINO ROBERTO
2012-01-01

Abstract

A dietary interview performed by expert personnel is the best method to check whether patients with coeliac disease follow a strict gluten-free diet (GFD). We previously developed a score based on flour fast and simple questions that can be administered even by non-expert personnel. The aim of the present study is to verify the reliability of our questionnaire in a new cohort of patients. The questionnaire has a five-level score. From March 2008 to January 2011, the questionnaire was administered to 141 coeliac patients on a GFD, who were undergoing re-evaluation. The score obtained was compared with persistence of both villous atrophy and endomysial antibodies (EMA). The rate of lower scores was higher among the patients with persistence of either villous atrophy (Fisher's excact, P < 0.001; test for trend, P < 0.001) or positive EMA (Fisher's exact, P = 0.001; test for trend, P = 0.018). Given that the coelic patients have been well instructed on what a GFD means and on how to follow it, our questionnaire is a reliable and simple method to verify compliance to a GFD.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/705419
Citazioni
  • ???jsp.display-item.citation.pmc??? 25
  • Scopus 98
  • ???jsp.display-item.citation.isi??? 93
social impact